Skip to content
ShodhX: Through Science, For Science

Research impact map

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Martin Jínek, Krzysztof Chylinski, Ines Fonfara, M. Hauer, Jennifer A. Doudna, Emmanuelle Charpentier

Published
Science, 2012
DOI
10.1126/science.1225829
Affiliations
Howard Hughes Medical Institute; University of California, Berkeley; University of Vienna; Max Perutz Labs; Umeå Centre for Microbial Research; Umeå University; Lawrence Berkeley National Laboratory
Literature search
2 Nov 2026, from OpenAlex, Semantic Scholar, Europe PMC

A. Executive scientific assessment

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems provide bacteria and archaea with adaptive immunity against viruses and plasmids by using CRISPR RNAs (crRNAs) to guide the silencing of invading nucleic acids. We show here that in a subset of these systems, the mature crRNA that is base-paired to trans-activating crRNA (tracrRNA) forms a two-RNA structure that directs the CRISPR-associated protein Cas9 to introduce double-stranded (ds) breaks in target DNA. At sites complementary to the crRNA-guide sequence, the Cas9 HNH nuclease domain cleaves the complementary strand, whereas the Cas9 RuvC-like domain cleaves the noncomplementary strand. The dual-tracrRNA:crRNA, when engineered as a single RNA chimera, also directs sequence-specific Cas9 dsDNA cleavage. Our study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.

The AI assessment, research themes and proposals are not available for this map. The verified citation data below are complete.

B. Dynamic citation network

Arrows point from each paper to the work it builds on, labelled with the relationship read from its citing sentence. Grey dotted arrows mean the paper cites the original but its citing sentence was not available, so no stronger claim is made. Drag to pan, scroll to zoom, click a paper for details.

Shapes: ◆ original · ▢ foundation · ● citing paper · ⬟ original team · ★ opportunity

C. Chronological research timeline

Year → research group → publication → finding or relationship → influence within this map. New group marks a group's first paper here.

1989 1 paper
  1. Foundation

    Molecular Cloning: A Laboratory Manual

    Joseph Sambrook · UCLA - Biblioteca de Ciencias de la Salud

    Cited by the original

    133,587 citations overall

2005 1 paper
  1. Foundation

    Massachusetts Institute of Technology, US

    Cited by the original

    11,855 citations overall

2007 3 papers
  1. Foundation

    Université Laval, CA

    Cited by the original

    6,306 citations overall

  2. Foundation

    Université Laval, CA

    Cited by the original

    1,213 citations overall

  3. Foundation

    Hôtel-Dieu de Québec, CA

    Argonaute proteins: key players in RNA silencing

    György Hutvágner · Nature Reviews Molecular Cell Biology

    Cited by the original

    1,362 citations overall

2008 1 paper
  1. Foundation

    National Institutes of Health, US

    Cited by the original

    2,593 citations overall

2009 2 papers
  1. Foundation

    University of Alicante, ES

    Cited by the original

    1,518 citations overall

  2. Foundation

    Université Paris-Sud, FR

    Cited by the original

    1,360 citations overall

2010 4 papers
  1. Foundation

    University of Minnesota, US

    Cited by the original

    2,030 citations overall

  2. Foundation

    Sangamo BioSciences (United States), US

    Genome editing with engineered zinc finger nucleases

    Fyodor D. Urnov · Nature Reviews Genetics

    Cited by the original

    2,285 citations overall

  3. Foundation

    Université Laval, CA

    Cited by the original

    2,336 citations overall

  4. Foundation

    Sangamo BioSciences (United States), US

    A TALE nuclease architecture for efficient genome editing

    Jeffrey C. Miller · Nature Biotechnology

    Cited by the original

    2,098 citations overall

2011 2 papers
  1. Foundation

    University of Vienna, AT

    Original team
    Cited by the original

    2,563 citations overall

  2. Foundation

    National Institutes of Health, US

    Original team

    Evolution and classification of the CRISPR–Cas systems

    Kira S. Makarova · Nature Reviews Microbiology

    Cited by the original

    2,512 citations overall

2012 2 papers · original article
  1. Foundation

    Howard Hughes Medical Institute, US

    Original team
    Cited by the original

    1,852 citations overall

  2. Original article

    Howard Hughes Medical Institute, US

    17,118 citations overall

2013 16 papers
  1. Le Cong

    Broad Institute, US

    New group
    Cites (sentence not available)

    15,342 citations overall ; cited by 34 later papers in this map

  2. Prashant Mali

    Harvard University, US

    New group
    Cites (sentence not available)

    9,213 citations overall ; cited by 30 later papers in this map

  3. J-R Joanna Yeh

    Harvard University, US

    New group
    Cites (sentence not available)

    2,937 citations overall ; cited by 13 later papers in this map

  4. David Bikard

    Rockefeller University, US

    New group
    Cites (sentence not available)

    2,430 citations overall ; cited by 15 later papers in this map

  5. Jennifer A. Doudna

    Howard Hughes Medical Institute, US

    Original team
    Cites (sentence not available)

    2,098 citations overall ; cited by 16 later papers in this map

  6. Lei S. Qi

    QB3, US

    New group Original team
    Cites (sentence not available)

    5,014 citations overall ; cited by 12 later papers in this map

  7. Rudolf Jaenisch

    Whitehead Institute for Biomedical Research, US

    New group
    Cites (sentence not available)

    3,495 citations overall ; cited by 14 later papers in this map

  8. Carlos F. Barbas

    Scripps Research Institute, US

    New group
    Cites (sentence not available)

    3,818 citations overall ; cited by 1 later paper in this map

  9. J. Keith Joung

    Harvard University, US

    New group

    High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

    Yanfang Fu · Nature Biotechnology

    “The Cas9 nuclease from S. pyogenes (hereafter simply Cas9) can be guided via simple base pair complementarity between the first 20 nucleotides of an engineered gRNA and a target genomic DNA sequence of interest that lies next to a protospac...”

    Cites as background

    3,294 citations overall ; cited by 17 later papers in this map

  10. Jonathan S. Weissman

    QB3, US

    New group Original team
    Cites (sentence not available)

    3,697 citations overall ; cited by 9 later papers in this map

  11. Feng Zhang

    Broad Institute, US

    New group

    DNA targeting specificity of RNA-guided Cas9 nucleases

    Patrick D. Hsu · Nature Biotechnology

    Cites (sentence not available)

    4,741 citations overall ; cited by 22 later papers in this map

  12. Feng Zhang

    Broad Institute, US

    Cites (sentence not available)

    3,300 citations overall ; cited by 13 later papers in this map

  13. Feng Zhang

    Broad Institute, US

    Genome engineering using the CRISPR-Cas9 system

    F. Ann Ran · Nature Protocols

    Cites (sentence not available)

    11,134 citations overall ; cited by 4 later papers in this map

  14. Lei S. Qi

    QB3, US

    Cites (sentence not available)

    1,967 citations overall ; cited by 3 later papers in this map

  15. Feng Zhang

    Broad Institute, US

    Cites (sentence not available)

    5,235 citations overall ; cited by 9 later papers in this map

  16. David M. Sabatini

    Broad Institute, US

    New group
    Cites (sentence not available)

    2,855 citations overall ; cited by 9 later papers in this map

2014 9 papers
  1. Sangsu Bae

    Seoul National University, KR

    New group
    Cites (sentence not available)

    2,340 citations overall ; cited by 4 later papers in this map

  2. Jeffry D. Sander

    Harvard University, US

    New group
    Cites (sentence not available)

    1,994 citations overall ; cited by 10 later papers in this map

  3. Feng Zhang

    Broad Institute, US

    Cites (sentence not available)

    2,307 citations overall ; cited by 13 later papers in this map

  4. J. Keith Joung

    Harvard University, US

    CRISPR-Cas systems for editing, regulating and targeting genomes

    Jeffry D. Sander · Nature Biotechnology

    Cites (sentence not available)

    3,153 citations overall ; cited by 9 later papers in this map

  5. Feng Zhang

    Broad Institute, US

    Cites (sentence not available)

    5,758 citations overall ; cited by 8 later papers in this map

  6. Phillip A. Sharp

    Koch Institute for Integrative Cancer Research At MIT, US

    New group
    Cites (sentence not available)

    2,001 citations overall

  7. Jennifer A. Doudna

    Howard Hughes Medical Institute, US

    Original team
    Cites (sentence not available)

    7,065 citations overall ; cited by 6 later papers in this map

  8. Feng Zhang

    Broad Institute, US

    Cites (sentence not available)

    2,825 citations overall ; cited by 2 later papers in this map

  9. Shengdar Q. Tsai

    Harvard University, US

    New group
    Cites (sentence not available)

    2,269 citations overall ; cited by 7 later papers in this map

2015 4 papers
  1. Feng Zhang

    Broad Institute, US

    In vivo genome editing using Staphylococcus aureus Cas9

    F. Ann Ran · Nature

    “Type II CRISPR-Cas systems require only two main components for eukaryotic genome editing: a Cas9 enzyme, and a chimeric single guide RNA (sgRNA)[*] derived from the CRISPR RNA (crRNA) and the noncoding trans-activating crRNA (tracrRNA)4,20...”

    Cites as background

    2,688 citations overall ; cited by 6 later papers in this map

  2. Yao‐Guang Liu

    South China Agricultural University, CN

    New group
    Cites (sentence not available)

    2,381 citations overall

  3. Feng Zhang

    Broad Institute, US

    Cites (sentence not available)

    4,808 citations overall ; cited by 8 later papers in this map

  4. Eugene V. Koonin

    National Institutes of Health, US

    Original team

    An updated evolutionary classification of CRISPR–Cas systems

    Kira S. Makarova · Nature Reviews Microbiology

    Cites (sentence not available)

    2,516 citations overall ; cited by 6 later papers in this map

2016 4 papers
  1. J. Keith Joung

    Harvard University, US

    Cites (sentence not available)

    2,670 citations overall ; cited by 7 later papers in this map

  2. John G. Doench

    Broad Institute, US

    New group

    Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

    John G. Doench · Nature Biotechnology

    “The Cas9 protein, an RNA-directed DNA endonuclease, is a powerful tool for manipulating the genome[*]-4.”

    Cites as background

    4,634 citations overall ; cited by 3 later papers in this map

  3. David R. Liu

    Howard Hughes Medical Institute, US

    New group

    Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

    Alexis C. Komor · Nature

    “Catalytically-dead Cas9 (dCas9), which contains Asp10Ala and His840Ala mutations that inactivate its nuclease activity, retains its ability to bind DNA in a guide RNA-programmed manner but does not cleave the DNA backbone.[*] In principle,...”

    Cites as background

    5,439 citations overall ; cited by 6 later papers in this map

  4. Eugene V. Koonin

    National Institutes of Health, US

    Cites (sentence not available)

    2,361 citations overall ; cited by 2 later papers in this map

2017 1 paper
  1. Jennifer A. Doudna

    QB3, US

    Original team

    CRISPR–Cas9 Structures and Mechanisms

    Fuguo Jiang · Annual Review of Biophysics

    Cites (sentence not available)

    2,029 citations overall ; cited by 1 later paper in this map

2018 1 paper
  1. Janice S. Chen

    University of California, Berkeley, US

    New group Original team
    Cites (sentence not available)

    4,512 citations overall ; cited by 3 later papers in this map

2019 1 paper
  1. David R. Liu

    Broad Institute, US

    Search-and-replace genome editing without double-strand breaks or donor DNA

    Andrew V. Anzalone · Nature

    “Programmable nucleases such as CRISPR-Cas9 make double-strand DNA breaks (DSBs) that can disrupt genes by inducing mixtures of insertions and deletions (indels) at target sites[*]–4.”

    Cites as background

    4,762 citations overall ; cited by 6 later papers in this map

2020 3 papers
  1. Daniel J. Siegwart

    Harold C. Simmons Comprehensive Cancer Center, US

    New group
    Cites (sentence not available)

    2,380 citations overall ; cited by 1 later paper in this map

  2. David R. Liu

    Broad Institute, US

    Cites (sentence not available)

    2,239 citations overall ; cited by 2 later papers in this map

  3. Thomas C. Roberts

    University of Oxford, GB

    New group

    Advances in oligonucleotide drug delivery

    Thomas C. Roberts · Nature Reviews Drug Discovery

    Cites (sentence not available)

    2,012 citations overall

2023 1 paper
  1. Alexander W. Rives

    New York University, US

    New group
    Cites (sentence not available)

    5,592 citations overall ; cited by 2 later papers in this map

2026 20 papers
  1. Xinrui Wang

    Jilin University, CN

    New group
    Cites (sentence not available)

    0 citations overall

  2. George P. Lisi

    Brown University, US

    New group
    Cites (sentence not available)

    0 citations overall

  3. Zheran Liu

    Sichuan University, CN

    New group
    Cites (sentence not available)

    0 citations overall

  4. Abdoulaye Diabaté

    Institut de Recherche en Sciences de la Santé, BF

    New group
    Cites (sentence not available)

    0 citations overall

  5. Nuo Si

    Chinese Academy of Medical Sciences & Peking Union Medical College, CN

    New group
    Cites (sentence not available)

    0 citations overall

  6. Marco Garbin

    Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, IT

    New group
    Cites (sentence not available)

    0 citations overall

  7. Xuyang Lu

    Jiangnan University, CN

    New group
    Cites (sentence not available)

    0 citations overall

  8. Simon Fischer

    Boehringer Ingelheim (Germany), DE

    New group
    Cites (sentence not available)

    0 citations overall

  9. Chaolong Rao

    Chengdu University of Traditional Chinese Medicine, CN

    New group

    miR-138-5p: From Multidimensional Tumor-Suppressive Regulatory Networks to Nanocarrier-Based Delivery for Solid Tumor Therapy

    Tian Leng · DARU Journal of Pharmaceutical Sciences

    “For instance, targeting these highly expressed “sponge” RNA molecules or designing antisense oligonucleotides that can specifically bind to such “sponge” RNAs may serve as an effective strategy to restore the tumor-suppressive activity of m...”

    Cites as background

    0 citations overall

  10. Diana Lee Farmer

    Shriners Hospitals for Children - Northern California, US

    New group

    Bioengineering strategies for prenatal therapy

    Elizabeth Reynolds · Nature Reviews Bioengineering

    Cites (sentence not available)

    0 citations overall

  11. Hao Yin

    Wuhan University, CN

    New group
    Cites (sentence not available)

    0 citations overall

  12. Yeni Wahyuni Hartati

    Padjadjaran University, ID

    New group

    CRISPR/Cas12-powered electrochemical biosensor for chikungunya virus DNA detection using gold-modified screen-printed carbon electrodes

    Clianta Yudin Kharismasari · ADMET & DMPK

    “The loop structure is important for Cas protein binding, structural stabilization of the ribonucleoprotein complex, and activation of nuclease activity after target recognition [27-29].”

    Cites as background

    0 citations overall

  13. Abdullah Mohammad Shohael

    Jahangirnagar University, BD

    New group

    Integrating Frontier Technologies to Achieve Semi-Dwarfism in Rice: Highlights on Genome Editing and Artificial Intelligence

    Md. Nazmussakib Shuvo · Crop Breeding Genetics and Genomics

    “In contrast, CRISPR-Cas genome editing instead uses an RNA-programmed nuclease whose specificity is dictated by guide RNA (gRNA) base pairing to the target DNA [101].”

    Cites as background

    0 citations overall

  14. Hoe‐Han Goh

    National University of Malaysia, MY

    New group
    Cites (sentence not available)

    0 citations overall

  15. Edyta Juszczuk‐Kubiak

    Institute of Agricultural and Food Biotechnology, PL

    New group
    Cites (sentence not available)

    0 citations overall

  16. Daniel H. Wolbrom

    Columbia University, US

    New group

    Nonischemic and normothermic beating cardiac xenotransplantation

    Daniel H. Wolbrom · Frontiers in Transplantation

    Cites (sentence not available)

    0 citations overall

  17. Raúl Ruiz

    Universitat de València, ES

    New group
    Cites (sentence not available)

    0 citations overall

  18. Zhu Baosheng

    Kunming University of Science and Technology, CN

    New group

    Research progress of gene correction for genetic diseases via in vivo prime editing

    Shuran Zhang · Molecular Genetics and Genomics

    “The CRISPR-Cas9 was recently developed and become the most widely used platforms of genome engineering (Jinek et al. 2012; Hryhorowicz et al. 2016; Kantor et al. 2020).”

    Cites as background

    0 citations overall

  19. Qing Chi Xu

    Nanjing Normal University, CN

    New group
    Cites (sentence not available)

    0 citations overall

  20. Eric N. Olson

    The University of Texas Southwestern Medical Center, US

    New group
    Cites (sentence not available)

    0 citations overall

D. Research group influence map

Groups are identified by the corresponding (or last) author of each citing paper in this map. Two groups are shown as collaborating only when their papers share an author.

Lead authorInstitution, countryYearsPapers and relationship to the originalCollaborates with
Le Cong Broad Institute, US 2013 Multiplex Genome Engineering Using CRISPR/Cas Systems (2013) · Cites (sentence not available) Feng Zhang, Rudolf Jaenisch, David Bikard, Phillip A. Sharp, Eugene V. Koonin
Feng Zhang Broad Institute, US 2013–2015 Genome engineering using the CRISPR-Cas9 system (2013) · Cites (sentence not available) Development and Applications of CRISPR-Cas9 for Genome Engineering (2014) · Cites (sentence not available) Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells (2013) · Cites (sentence not available) Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas Syste... (2015) · Cites (sentence not available) DNA targeting specificity of RNA-guided Cas9 nucleases (2013) · Cites (sentence not available) Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing S... (2013) · Cites (sentence not available) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 c... (2014) · Cites (sentence not available) In vivo genome editing using Staphylococcus aureus Cas9 (2015) · Cites as background Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA (2014) · Cites (sentence not available) Le Cong, Rudolf Jaenisch, David M. Sabatini, David Bikard, Phillip A. Sharp, Eugene V. Koonin, John G. Doench
Prashant Mali Harvard University, US 2013 RNA-Guided Human Genome Engineering via Cas9 (2013) · Cites (sentence not available) —
Jennifer A. Doudnaoriginal team Howard Hughes Medical Institute, US 2013–2017 The new frontier of genome engineering with CRISPR-Cas9 (2014) · Cites (sentence not available) RNA-programmed genome editing in human cells (2013) · Cites (sentence not available) CRISPR–Cas9 Structures and Mechanisms (2017) · Cites (sentence not available) Lei S. Qi, Jonathan S. Weissman, Eugene V. Koonin, Janice S. Chen
Lei S. Qioriginal team QB3, US 2013 Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Con... (2013) · Cites (sentence not available) Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized... (2013) · Cites (sentence not available) Jennifer A. Doudna, Jonathan S. Weissman, Janice S. Chen
Carlos F. Barbas Scripps Research Institute, US 2013 ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering (2013) · Cites (sentence not available) —
Jonathan S. Weissmanoriginal team QB3, US 2013 CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Euka... (2013) · Cites (sentence not available) Jennifer A. Doudna, Lei S. Qi, Janice S. Chen
Rudolf Jaenisch Whitehead Institute for Biomedical Research, US 2013 One-Step Generation of Mice Carrying Mutations in Multiple Genes by CR... (2013) · Cites (sentence not available) Le Cong, Feng Zhang, David Bikard, Phillip A. Sharp, Eugene V. Koonin
J. Keith Joung Harvard University, US 2013–2016 High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases... (2013) · Cites as background CRISPR-Cas systems for editing, regulating and targeting genomes (2014) · Cites (sentence not available) High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off... (2016) · Cites (sentence not available) J-R Joanna Yeh, Shengdar Q. Tsai, Jeffry D. Sander
J-R Joanna Yeh Harvard University, US 2013 Efficient genome editing in zebrafish using a CRISPR-Cas system (2013) · Cites (sentence not available) J. Keith Joung, Shengdar Q. Tsai, Jeffry D. Sander
David M. Sabatini Broad Institute, US 2013 Genetic Screens in Human Cells Using the CRISPR-Cas9 System (2013) · Cites (sentence not available) Feng Zhang, Eugene V. Koonin
David Bikard Rockefeller University, US 2013 RNA-guided editing of bacterial genomes using CRISPR-Cas systems (2013) · Cites (sentence not available) Le Cong, Feng Zhang, Rudolf Jaenisch, Phillip A. Sharp, Eugene V. Koonin
Sangsu Bae Seoul National University, KR 2014 Cas-OFFinder: a fast and versatile algorithm that searches for potenti... (2014) · Cites (sentence not available) —
Shengdar Q. Tsai Harvard University, US 2014 GUIDE-seq enables genome-wide profiling of off-target cleavage by CRIS... (2014) · Cites (sentence not available) J. Keith Joung, J-R Joanna Yeh, Jeffry D. Sander
Phillip A. Sharp Koch Institute for Integrative Cancer Research At MIT, US 2014 CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling (2014) · Cites (sentence not available) Le Cong, Feng Zhang, Rudolf Jaenisch, David Bikard, Eugene V. Koonin, Thomas C. Roberts
Jeffry D. Sander Harvard University, US 2014 Improving CRISPR-Cas nuclease specificity using truncated guide RNAs (2014) · Cites (sentence not available) J. Keith Joung, J-R Joanna Yeh, Shengdar Q. Tsai
Eugene V. Kooninoriginal team National Institutes of Health, US 2015–2016 An updated evolutionary classification of CRISPR–Cas systems (2015) · Cites (sentence not available) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISP... (2016) · Cites (sentence not available) Le Cong, Feng Zhang, Jennifer A. Doudna, Rudolf Jaenisch, David M. Sabatini, David Bikard, Phillip A. Sharp
Yao‐Guang Liu South China Agricultural University, CN 2015 A Robust CRISPR/Cas9 System for Convenient, High-Efficiency Multiplex... (2015) · Cites (sentence not available) —
David R. Liu Broad Institute, US 2016–2020 Programmable editing of a target base in genomic DNA without double-st... (2016) · Cites as background Search-and-replace genome editing without double-strand breaks or dono... (2019) · Cites as background Genome editing with CRISPR–Cas nucleases, base editors, transposases a... (2020) · Cites (sentence not available) —
John G. Doench Broad Institute, US 2016 Optimized sgRNA design to maximize activity and minimize off-target ef... (2016) · Cites as background Feng Zhang
Janice S. Chenoriginal team University of California, Berkeley, US 2018 CRISPR-Cas12a target binding unleashes indiscriminate single-stranded... (2018) · Cites (sentence not available) Jennifer A. Doudna, Lei S. Qi, Jonathan S. Weissman
Daniel J. Siegwart Harold C. Simmons Comprehensive Cancer Center, US 2020 Selective organ targeting (SORT) nanoparticles for tissue-specific mRN... (2020) · Cites (sentence not available) —
Thomas C. Roberts University of Oxford, GB 2020 Advances in oligonucleotide drug delivery (2020) · Cites (sentence not available) Phillip A. Sharp
Alexander W. Rives New York University, US 2023 Evolutionary-scale prediction of atomic-level protein structure with a... (2023) · Cites (sentence not available) —
Eric N. Olson The University of Texas Southwestern Medical Center, US 2026 A single liver-sparing myotropic AAV ameliorates muscular dystrophy in... (2026) · Cites (sentence not available) —
Qing Chi Xu Nanjing Normal University, CN 2026 Clustered Regularly Interspaced Palindromic Repeats–Cas Genome-Editing... (2026) · Cites (sentence not available) —
Edyta Juszczuk‐Kubiak Institute of Agricultural and Food Biotechnology, PL 2026 CRISPR/Cas in food microbial biotechnology: from genome editing to pre... (2026) · Cites (sentence not available) —
Daniel H. Wolbrom Columbia University, US 2026 Nonischemic and normothermic beating cardiac xenotransplantation (2026) · Cites (sentence not available) —
Raúl Ruiz Universitat de València, ES 2026 Computational Design of Prokaryotic Translation Regulation Based on RN... (2026) · Cites (sentence not available) —
Zhu Baosheng Kunming University of Science and Technology, CN 2026 Research progress of gene correction for genetic diseases via in vivo... (2026) · Cites as background —
Hoe‐Han Goh National University of Malaysia, MY 2026 Systems biology and synthetic engineering of probiotic yeasts (2026) · Cites (sentence not available) —
Yeni Wahyuni Hartati Padjadjaran University, ID 2026 CRISPR/Cas12-powered electrochemical biosensor for chikungunya virus D... (2026) · Cites as background —
Abdullah Mohammad Shohael Jahangirnagar University, BD 2026 Integrating Frontier Technologies to Achieve Semi-Dwarfism in Rice: Hi... (2026) · Cites as background —
Diana Lee Farmer Shriners Hospitals for Children - Northern California, US 2026 Bioengineering strategies for prenatal therapy (2026) · Cites (sentence not available) —
Hao Yin Wuhan University, CN 2026 Efficient and precise large-scale genomic duplication using amplificat... (2026) · Cites (sentence not available) —
Simon Fischer Boehringer Ingelheim (Germany), DE 2026 The historical evolution of CHO cell line development for biologics pr... (2026) · Cites (sentence not available) —
Chaolong Rao Chengdu University of Traditional Chinese Medicine, CN 2026 miR-138-5p: From Multidimensional Tumor-Suppressive Regulatory Network... (2026) · Cites as background —
Marco Garbin Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, IT 2026 ORFan genes and capsid architectures in giant viruses: two structure-g... (2026) · Cites (sentence not available) —
Xuyang Lu Jiangnan University, CN 2026 In Vivo Continuous Evolution Systems: Overview, Principles and Applica... (2026) · Cites (sentence not available) —
George P. Lisi Brown University, US 2026 Visualizing the Atomic-Level Impact of Anti-CRISPR II–C1 Inhibition on... (2026) · Cites (sentence not available) —
Zheran Liu Sichuan University, CN 2026 Innovations and emerging trends in adoptive cell therapies for solid t... (2026) · Cites (sentence not available) —
Abdoulaye Diabaté Institut de Recherche en Sciences de la Santé, BF 2026 Identification and evaluation of a gRNA targeting the Nudel gene to ad... (2026) · Cites (sentence not available) —
Nuo Si Chinese Academy of Medical Sciences & Peking Union Medical College, CN 2026 Precision Gene Therapy for Monogenic Neurological Disorders: Emerging... (2026) · Cites (sentence not available) —
Xinrui Wang Jilin University, CN 2026 A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing... (2026) · Cites (sentence not available) —

E. Research opportunity map

Research opportunities are written by AI and are not available for this map.

F. Comprehensive citation table

The 15 most-cited studies the original builds on, and 60 of its 17,118 citing papers (the most cited and the most recent). 9 have a citing sentence; the rest are marked “Cites (sentence not available)”.

RoleFirst authorYearTitleJournalDOIInstitutionRelationshipEvidence (citing sentence)
Foundation Joseph Sambrook 1989 Molecular Cloning: A Laboratory Manual UCLA - Biblioteca de Ciencias de la Salud Cited by the original
Foundation Benjamin P. Lewis 2005 Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets Cell 10.1016/j.cell.2004.12.035 Massachusetts Institute of Technology Cited by the original
Foundation Rodolphe Barrangou 2007 CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes Science 10.1126/science.1138140 Université Laval Cited by the original
Foundation György Hutvágner 2007 Argonaute proteins: key players in RNA silencing Nature Reviews Molecular Cell Biology 10.1038/nrm2321 Hôtel-Dieu de Québec Cited by the original
Foundation Hélène Deveau 2007 Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus Journal of Bacteriology 10.1128/jb.01412-07 Université Laval Cited by the original
Foundation Stan J. J. Brouns 2008 Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes Science 10.1126/science.1159689 National Institutes of Health Cited by the original
Foundation Francisco J. M. Mojica 2009 Short motif sequences determine the targets of the prokaryotic CRISPR defence system Microbiology 10.1099/mic.0.023960-0 University of Alicante Cited by the original
Foundation Kévin Darty 2009 VARNA: Interactive drawing and editing of the RNA secondary structure Bioinformatics 10.1093/bioinformatics/btp250 Université Paris-Sud Cited by the original
Foundation Josiane E. Garneau 2010 The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA Nature 10.1038/nature09523 Université Laval Cited by the original
Foundation Fyodor D. Urnov 2010 Genome editing with engineered zinc finger nucleases Nature Reviews Genetics 10.1038/nrg2842 Sangamo BioSciences (United States) Cited by the original
Foundation Jeffrey C. Miller 2010 A TALE nuclease architecture for efficient genome editing Nature Biotechnology 10.1038/nbt.1755 Sangamo BioSciences (United States) Cited by the original
Foundation Michelle L. Christian 2010 Targeting DNA Double-Strand Breaks with TAL Effector Nucleases Genetics 10.1534/genetics.110.120717 University of Minnesota Cited by the original
Foundation (same team) Elitza M. Deltcheva 2011 CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III Nature 10.1038/nature09886 University of Vienna Cited by the original
Foundation (same team) Kira S. Makarova 2011 Evolution and classification of the CRISPR–Cas systems Nature Reviews Microbiology 10.1038/nrmicro2577 National Institutes of Health Cited by the original
Foundation (same team) Blake Wiedenheft 2012 RNA-guided genetic silencing systems in bacteria and archaea Nature 10.1038/nature10886 Howard Hughes Medical Institute Cited by the original
Citing paper Le Cong 2013 Multiplex Genome Engineering Using CRISPR/Cas Systems Science 10.1126/science.1231143 Broad Institute Cites (sentence not available)
Citing paper F. Ann Ran 2013 Genome engineering using the CRISPR-Cas9 system Nature Protocols 10.1038/nprot.2013.143 Broad Institute Cites (sentence not available)
Citing paper Prashant Mali 2013 RNA-Guided Human Genome Engineering via Cas9 Science 10.1126/science.1232033 Harvard University Cites (sentence not available)
Citing paper Ophir Shalem 2013 Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells Science 10.1126/science.1247005 Broad Institute Cites (sentence not available)
Citing paper (same team) Lei S. Qi 2013 Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression Cell 10.1016/j.cell.2013.02.022 QB3 Cites (sentence not available)
Citing paper Patrick D. Hsu 2013 DNA targeting specificity of RNA-guided Cas9 nucleases Nature Biotechnology 10.1038/nbt.2647 Broad Institute Cites (sentence not available)
Citing paper Thomas Gaj 2013 ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering Trends in biotechnology 10.1016/j.tibtech.2013.04.004 Scripps Research Institute Cites (sentence not available)
Citing paper (same team) Luke A. Gilbert 2013 CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes Cell 10.1016/j.cell.2013.06.044 QB3 Cites (sentence not available)
Citing paper Haoyi Wang 2013 One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering Cell 10.1016/j.cell.2013.04.025 Whitehead Institute for Biomedical Research Cites (sentence not available)
Citing paper F. Ann Ran 2013 Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity Cell 10.1016/j.cell.2013.08.021 Broad Institute Cites (sentence not available)
Citing paper Yanfang Fu 2013 High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells Nature Biotechnology 10.1038/nbt.2623 Harvard University Cites as background The Cas9 nuclease from S. pyogenes (hereafter simply Cas9) can be guided via simple base pair complementarity between the first 20 nucleotides of an engineered gRNA and a target genomic DNA sequence of interest that lies next to a protospacer adjacent motif (PAM) matching the sequence NGG5–12, [*] (Supplementary Fig. 1).Source: Europe PMC
Citing paper Woong Y. Hwang 2013 Efficient genome editing in zebrafish using a CRISPR-Cas system Nature Biotechnology 10.1038/nbt.2501 Harvard University Cites (sentence not available)
Citing paper Wang Tim 2013 Genetic Screens in Human Cells Using the CRISPR-Cas9 System Science 10.1126/science.1246981 Broad Institute Cites (sentence not available)
Citing paper Wenyan Jiang 2013 RNA-guided editing of bacterial genomes using CRISPR-Cas systems Nature Biotechnology 10.1038/nbt.2508 Rockefeller University Cites (sentence not available)
Citing paper (same team) Martin Jínek 2013 RNA-programmed genome editing in human cells eLife 10.7554/elife.00471 Howard Hughes Medical Institute Cites (sentence not available)
Citing paper Baohui Chen 2013 Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System Cell 10.1016/j.cell.2013.12.001 QB3 Cites (sentence not available)
Citing paper (same team) Jennifer A. Doudna 2014 The new frontier of genome engineering with CRISPR-Cas9 Science 10.1126/science.1258096 Howard Hughes Medical Institute Cites (sentence not available)
Citing paper Patrick D. Hsu 2014 Development and Applications of CRISPR-Cas9 for Genome Engineering Cell 10.1016/j.cell.2014.05.010 Broad Institute Cites (sentence not available)
Citing paper Jeffry D. Sander 2014 CRISPR-Cas systems for editing, regulating and targeting genomes Nature Biotechnology 10.1038/nbt.2842 Harvard University Cites (sentence not available)
Citing paper Silvana Konermann 2014 Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex Nature 10.1038/nature14136 Broad Institute Cites (sentence not available)
Citing paper Sangsu Bae 2014 Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases Bioinformatics 10.1093/bioinformatics/btu048 Seoul National University Cites (sentence not available)
Citing paper Hiroshi Nishimasu 2014 Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA Cell 10.1016/j.cell.2014.02.001 Broad Institute Cites (sentence not available)
Citing paper Shengdar Q. Tsai 2014 GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases Nature Biotechnology 10.1038/nbt.3117 Harvard University Cites (sentence not available)
Citing paper Randall J. Platt 2014 CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling Cell 10.1016/j.cell.2014.09.014 Koch Institute for Integrative Cancer Research At MIT Cites (sentence not available)
Citing paper Yanfang Fu 2014 Improving CRISPR-Cas nuclease specificity using truncated guide RNAs Nature Biotechnology 10.1038/nbt.2808 Harvard University Cites (sentence not available)
Citing paper Bernd Zetsche 2015 Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System Cell 10.1016/j.cell.2015.09.038 Broad Institute Cites (sentence not available)
Citing paper F. Ann Ran 2015 In vivo genome editing using Staphylococcus aureus Cas9 Nature 10.1038/nature14299 Broad Institute Cites as background Type II CRISPR-Cas systems require only two main components for eukaryotic genome editing: a Cas9 enzyme, and a chimeric single guide RNA (sgRNA)[*] derived from the CRISPR RNA (crRNA) and the noncoding trans-activating crRNA (tracrRNA)4,20.Source: Europe PMC
Citing paper (same team) Kira S. Makarova 2015 An updated evolutionary classification of CRISPR–Cas systems Nature Reviews Microbiology 10.1038/nrmicro3569 National Institutes of Health Cites (sentence not available)
Citing paper Xingliang Ma 2015 A Robust CRISPR/Cas9 System for Convenient, High-Efficiency Multiplex Genome Editing in Monocot and Dicot Plants Molecular Plant 10.1016/j.molp.2015.04.007 South China Agricultural University Cites (sentence not available)
Citing paper Alexis C. Komor 2016 Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage Nature 10.1038/nature17946 Howard Hughes Medical Institute Cites as background Catalytically-dead Cas9 (dCas9), which contains Asp10Ala and His840Ala mutations that inactivate its nuclease activity, retains its ability to bind DNA in a guide RNA-programmed manner but does not cleave the DNA backbone.[*] In principle, conjugation of dCas9 with an enzymatic or chemical catalyst that mediates the direct conversion of one base to another could enable RNA-programmed DNA base editing.Source: Europe PMC
Citing paper John G. Doench 2016 Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 Nature Biotechnology 10.1038/nbt.3437 Broad Institute Cites as background The Cas9 protein, an RNA-directed DNA endonuclease, is a powerful tool for manipulating the genome[*]-4.Source: Europe PMC
Citing paper Benjamin P. Kleinstiver 2016 High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects Nature 10.1038/nature16526 Harvard University Cites (sentence not available)
Citing paper Omar O. Abudayyeh 2016 C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector Science 10.1126/science.aaf5573 National Institutes of Health Cites (sentence not available)
Citing paper (same team) Fuguo Jiang 2017 CRISPR–Cas9 Structures and Mechanisms Annual Review of Biophysics 10.1146/annurev-biophys-062215-010822 QB3 Cites (sentence not available)
Citing paper (same team) Janice S. Chen 2018 CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity Science 10.1126/science.aar6245 University of California, Berkeley Cites (sentence not available)
Citing paper Andrew V. Anzalone 2019 Search-and-replace genome editing without double-strand breaks or donor DNA Nature 10.1038/s41586-019-1711-4 Broad Institute Cites as background Programmable nucleases such as CRISPR-Cas9 make double-strand DNA breaks (DSBs) that can disrupt genes by inducing mixtures of insertions and deletions (indels) at target sites[*]–4.Source: Europe PMC
Citing paper Qiang Cheng 2020 Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing Nature Nanotechnology 10.1038/s41565-020-0669-6 Harold C. Simmons Comprehensive Cancer Center Cites (sentence not available)
Citing paper Andrew V. Anzalone 2020 Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors Nature Biotechnology 10.1038/s41587-020-0561-9 Broad Institute Cites (sentence not available)
Citing paper Thomas C. Roberts 2020 Advances in oligonucleotide drug delivery Nature Reviews Drug Discovery 10.1038/s41573-020-0075-7 University of Oxford Cites (sentence not available)
Citing paper Zeming Lin 2023 Evolutionary-scale prediction of atomic-level protein structure with a language model Science 10.1126/science.ade2574 New York University Cites (sentence not available)
Citing paper Yu-Chung Pien 2026 A single liver-sparing myotropic AAV ameliorates muscular dystrophy in humanized mice by base editing Journal of Clinical Investigation 10.1172/jci202378 The University of Texas Southwestern Medical Center Cites (sentence not available)
Citing paper Rubing Du 2026 Clustered Regularly Interspaced Palindromic Repeats–Cas Genome-Editing Systems in Filamentous Fungi: Current Tools, Optimization Strategies, and Future Perspectives Journal of Agricultural and Food Chemistry 10.1021/acs.jafc.6c12748 Nanjing Normal University Cites (sentence not available)
Citing paper Edyta Juszczuk‐Kubiak 2026 CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology Frontiers in Microbiology 10.3389/fmicb.2026.1996037 Institute of Agricultural and Food Biotechnology Cites (sentence not available)
Citing paper Daniel H. Wolbrom 2026 Nonischemic and normothermic beating cardiac xenotransplantation Frontiers in Transplantation 10.3389/frtra.2026.1984456 Columbia University Cites (sentence not available)
Citing paper Raúl Ruiz 2026 Computational Design of Prokaryotic Translation Regulation Based on RNA-Binding Proteins Methods in molecular biology 10.1007/978-1-0716-5583-2_4 Universitat de València Cites (sentence not available)
Citing paper Shuran Zhang 2026 Research progress of gene correction for genetic diseases via in vivo prime editing Molecular Genetics and Genomics 10.1007/s00438-026-02535-8 Kunming University of Science and Technology Cites as background The CRISPR-Cas9 was recently developed and become the most widely used platforms of genome engineering (Jinek et al. 2012; Hryhorowicz et al. 2016; Kantor et al. 2020).Source: Semantic Scholar
Citing paper Saqib Ali 2026 Systems biology and synthetic engineering of probiotic yeasts Biotechnology Advances 10.1016/j.biotechadv.2026.109084 National University of Malaysia Cites (sentence not available)
Citing paper Clianta Yudin Kharismasari 2026 CRISPR/Cas12-powered electrochemical biosensor for chikungunya virus DNA detection using gold-modified screen-printed carbon electrodes ADMET & DMPK 10.5599/admet.3564 Padjadjaran University Cites as background The loop structure is important for Cas protein binding, structural stabilization of the ribonucleoprotein complex, and activation of nuclease activity after target recognition [27-29].Source: Semantic Scholar
Citing paper Md. Nazmussakib Shuvo 2026 Integrating Frontier Technologies to Achieve Semi-Dwarfism in Rice: Highlights on Genome Editing and Artificial Intelligence Crop Breeding Genetics and Genomics 10.20900/cbgg20260024 Jahangirnagar University Cites as background In contrast, CRISPR-Cas genome editing instead uses an RNA-programmed nuclease whose specificity is dictated by guide RNA (gRNA) base pairing to the target DNA [101].Source: Semantic Scholar
Citing paper Elizabeth Reynolds 2026 Bioengineering strategies for prenatal therapy Nature Reviews Bioengineering 10.1038/s44222-026-00501-y Shriners Hospitals for Children - Northern California Cites (sentence not available)
Citing paper Sisi Xie 2026 Efficient and precise large-scale genomic duplication using amplification editing Nature Protocols 10.1038/s41596-026-01454-7 Wuhan University Cites (sentence not available)
Citing paper Juergen Fieder 2026 The historical evolution of CHO cell line development for biologics production: 60 years and still counting Critical Reviews in Biotechnology 10.1080/07388551.2026.2738418 Boehringer Ingelheim (Germany) Cites (sentence not available)
Citing paper Tian Leng 2026 miR-138-5p: From Multidimensional Tumor-Suppressive Regulatory Networks to Nanocarrier-Based Delivery for Solid Tumor Therapy DARU Journal of Pharmaceutical Sciences 10.1007/s40199-026-00683-1 Chengdu University of Traditional Chinese Medicine Cites as background For instance, targeting these highly expressed “sponge” RNA molecules or designing antisense oligonucleotides that can specifically bind to such “sponge” RNAs may serve as an effective strategy to restore the tumor-suppressive activity of miR-138-5p [55, 56, 58, 59].Source: Semantic Scholar
Citing paper Marco Garbin 2026 ORFan genes and capsid architectures in giant viruses: two structure-guided hypotheses for biomedical innovation Medical Hypotheses 10.1016/j.mehy.2026.112218 Università degli Studi del Piemonte Orientale “Amedeo Avogadro” Cites (sentence not available)
Citing paper Xuyang Lu 2026 In Vivo Continuous Evolution Systems: Overview, Principles and Applications ACS Synthetic Biology 10.1021/acssynbio.6c00481 Jiangnan University Cites (sentence not available)
Citing paper Alexa L Knight 2026 Visualizing the Atomic-Level Impact of Anti-CRISPR II–C1 Inhibition on Geo Cas9 with Integrated Structural Biophysics JACS Au 10.1021/jacsau.6c00870 Brown University Cites (sentence not available)
Citing paper Peng Huang 2026 Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation Experimental Hematology and Oncology 10.1186/s40164-026-00848-3 Sichuan University Cites (sentence not available)
Citing paper Achaz A. M. Agolinou 2026 Identification and evaluation of a gRNA targeting the Nudel gene to adapt a gene drive system from Anopheles gambiae to Anopheles funestus for genetic control 10.12688/verixiv.3174.2 Institut de Recherche en Sciences de la Santé Cites (sentence not available)
Citing paper Jiawei Du 2026 Precision Gene Therapy for Monogenic Neurological Disorders: Emerging Technologies, Safety, and Mechanism–Modality Matching Genes 10.3390/genes17111321 Chinese Academy of Medical Sciences & Peking Union Medical College Cites (sentence not available)
Citing paper Xinrui Wang 2026 A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus Biosensors and Bioelectronics 10.1016/j.bios.2026.119360 Jilin University Cites (sentence not available)

G. Research strategy report

Research proposals are written by AI and are not available for this map.

Quantitative research impact

Total citations
17,118
Verified, OpenAlex
Citing papers in this map
60
Most cited + most recent
With citing sentence
9
Semantic Scholar, Europe PMC
Distinct research groups
44
In this map
Self-citations
7
Citing papers sharing an author

Citations per year

All citing works in OpenAlex, 2 Nov 2026; the current year is incomplete.

  • 1889 1
  • 1952 1
  • 1965 1
  • 1978 1
  • 1982 1
  • 1983 1+0%
  • 1989 1
  • 1995 1
  • 1999 2
  • 2002 1
  • 2005 1
  • 2006 1+0%
  • 2008 2
  • 2010 1
  • 2011 1+0%
  • 2012 29+2800%
  • 2013 231+697%
  • 2014 467+102%
  • 2015 680+46%
  • 2016 1,018+50%
  • 2017 1,141+12%
  • 2018 1,257+10%
  • 2019 1,344+7%
  • 2020 1,545+15%
  • 2021 1,744+13%
  • 2022 1,777+2%
  • 2023 1,562-12%
  • 2024 1,577+1%
  • 2025 1,500-5%
  • 2026 1,084-28%

Citing works by country

All citing works in OpenAlex; a paper counts once for each country or institution of its authors.

  1. United States5,701
  2. China3,349
  3. India1,217
  4. Germany1,204
  5. United Kingdom1,019
  6. Japan887
  7. France611
  8. South Korea584
  9. Canada535
  10. Australia431
  11. Netherlands424
  12. Spain346
  13. Italy337
  14. Switzerland283
  15. Denmark270

Citing works by institution

All citing works in OpenAlex; a paper counts once for each country or institution of its authors.

  1. Chinese Academy of Sciences626
  2. Harvard University489
  3. Howard Hughes Medical Institute393
  4. University of California, Berkeley357
  5. University of California, San Francisco324
  6. University of Chinese Academy of Sciences310
  7. Stanford University292
  8. Centre National de la Recherche Scientifique276
  9. State Council of the People's Republic of China272
  10. Massachusetts Institute of Technology254
  11. Helmholtz Association of German Research Centres252
  12. Ministry of Agriculture and Rural Affairs251
  13. United States Department of Health and Human Services225
  14. Broad Institute222
  15. National Institutes of Health214

Research topics of citing works

CRISPR and Genetic Engineering (9,199) · RNA Interference and Gene Delivery (298) · Microbial Metabolic Engineering and Bioproduction (280) · Pluripotent Stem Cells Research (223) · Virus-based gene therapy research (219) · Advanced biosensing and bioanalysis techniques (208) · Biosensors and Analytical Detection (204) · Genetically Modified Organisms Research (157) · Animal Genetics and Reproduction (155) · Genomics and Chromatin Dynamics (117)

Relationships found in this map

  • Cites (sentence not available): 51
  • Cites as background: 9

Most influential follow-up publications

Ranked by how many other papers in this map cite them, then by total citations. Citation counts measure attention, not validation.

  1. Le Cong (2013). Multiplex Genome Engineering Using CRISPR/Cas Systems. 15,342 citations; cited by 34 in this map.
  2. Prashant Mali (2013). RNA-Guided Human Genome Engineering via Cas9. 9,213 citations; cited by 30 in this map.
  3. Patrick D. Hsu (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. 4,741 citations; cited by 22 in this map.
  4. Yanfang Fu (2013). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. 3,294 citations; cited by 17 in this map.
  5. Martin Jínek (2013). RNA-programmed genome editing in human cells. 2,098 citations; cited by 16 in this map.

Bibliography (APA)

All references were retrieved from OpenAlex on 2 Nov 2026; every entry has a DOI or OpenAlex record.

  1. Agolinou, A. A. M., Brenas, J., Yemien, S. O. G., Pescod, P., Page, N., Humphreys, H., Lanfrancotti, A., Zongo, N. O., Kaboré, H., Sawadogo, G., Chumbé, S., Diallo, I., et al. (2026). Identification and evaluation of a gRNA targeting the Nudel gene to adapt a gene drive system from Anopheles gambiae to Anopheles funestus for genetic control. https://doi.org/10.12688/verixiv.3174.2
  2. Knight, A. L., Belato, H. B., Lasekan, P., Dresser, C. S., Pindi, C., Mercado, B. J., Luo, J., Jogl, G., Palermo, G., & Lisi, G. P. (2026). Visualizing the Atomic-Level Impact of Anti-CRISPR II–C1 Inhibition on Geo Cas9 with Integrated Structural Biophysics. JACS Au. https://doi.org/10.1021/jacsau.6c00870
  3. Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. https://doi.org/10.1038/nature17946
  4. Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., & Liu, D. R. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. https://doi.org/10.1038/s41586-019-1711-4
  5. Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020). Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nature Biotechnology. https://doi.org/10.1038/s41587-020-0561-9
  6. Chen, B., Gilbert, L. A., Cimini, B. A., Schnitzbauer, J., Zhang, W., Li, G., Park, J. S., Blackburn, E. H., Weissman, J. S., Qi, L. S., & Huang, B. (2013). Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System. Cell. https://doi.org/10.1016/j.cell.2013.12.001
  7. Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016). High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects. Nature. https://doi.org/10.1038/nature16526
  8. Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell. https://doi.org/10.1016/j.cell.2004.12.035
  9. Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., OOST, J. v. d., Regev, A., Koonin, E. V., & Zhang, F. (2015). Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System. Cell. https://doi.org/10.1016/j.cell.2015.09.038
  10. Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012). RNA-guided genetic silencing systems in bacteria and archaea. Nature. https://doi.org/10.1038/nature10886
  11. Kharismasari, C. Y., Zakiyyah, S. N., Zein, M. I. H., Hardianto, A., Mirasoli, M., Irkham, I., & Hartati, Y. W. (2026). CRISPR/Cas12-powered electrochemical biosensor for chikungunya virus DNA detection using gold-modified screen-printed carbon electrodes. ADMET & DMPK. https://doi.org/10.5599/admet.3564
  12. Wolbrom, D. H., Matsumura, N., Moroi, M. K., Chauhan, I., Fujiwara, S., Qudus, S., Brewer, M., Ekanayake‐Alper, D. K., Hajosi, D., Schweitzer, L., Takeda, K., Levy, R. J., et al. (2026). Nonischemic and normothermic beating cardiac xenotransplantation. Frontiers in Transplantation. https://doi.org/10.3389/frtra.2026.1984456
  13. Juszczuk‐Kubiak, E., Piłka, N., Zielińska, E., & Roszko, M. Ł. (2026). CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2026.1996037
  14. Deltcheva, E. M., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011). CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. https://doi.org/10.1038/nature09886
  15. Reynolds, E., Farmer, D. L., & Wang, A. (2026). Bioengineering strategies for prenatal therapy. Nature Reviews Bioengineering. https://doi.org/10.1038/s44222-026-00501-y
  16. Ran, F. A., Hsu, P. D., Wright, J. B., Agarwala, V., Scott, D. A., & Zhang, F. (2013). Genome engineering using the CRISPR-Cas9 system. Nature Protocols. https://doi.org/10.1038/nprot.2013.143
  17. Ran, F. A., Hsu, P. D., Lin, C., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., & Zhang, F. (2013). Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity. Cell. https://doi.org/10.1016/j.cell.2013.08.021
  18. Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., Koonin, E. V., Sharp, P. A., et al. (2015). In vivo genome editing using Staphylococcus aureus Cas9. Nature. https://doi.org/10.1038/nature14299
  19. Mojica, F. J. M., Díez‐Villaseñor, C., García‐Martínez, J., & Almendros, C. (2009). Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology. https://doi.org/10.1099/mic.0.023960-0
  20. Jiang, F., & Doudna, J. A. (2017). CRISPR–Cas9 Structures and Mechanisms. Annual Review of Biophysics. https://doi.org/10.1146/annurev-biophys-062215-010822
  21. Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010). Genome editing with engineered zinc finger nucleases. Nature Reviews Genetics. https://doi.org/10.1038/nrg2842
  22. Hutvágner, G., & Simard, M. J. (2007). Argonaute proteins: key players in RNA silencing. Nature Reviews Molecular Cell Biology. https://doi.org/10.1038/nrm2321
  23. Wang, H., Yang, H., Shivalila, C., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013). One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering. Cell. https://doi.org/10.1016/j.cell.2013.04.025
  24. Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014). Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA. Cell. https://doi.org/10.1016/j.cell.2014.02.001
  25. Deveau, H., Barrangou, R., Garneau, J. E., Labonté, J., Fremaux, C., Boyaval, P., Romero, D. A., Horvath, P., & Moineau, S. (2007). Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus. Journal of Bacteriology. https://doi.org/10.1128/jb.01412-07
  26. Chen, J. S., Ma, E., Harrington, L. B., Costa, M. D., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018). CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. https://doi.org/10.1126/science.aar6245
  27. Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., Dulay, G. P., Hua, K. L., et al. (2010). A TALE nuclease architecture for efficient genome editing. Nature Biotechnology. https://doi.org/10.1038/nbt.1755
  28. Sander, J. D., & Joung, J. K. (2014). CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology. https://doi.org/10.1038/nbt.2842
  29. Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science. https://doi.org/10.1126/science.1258096
  30. Du, J., Meng, X., Fan, P., & Si, N. (2026). Precision Gene Therapy for Monogenic Neurological Disorders: Emerging Technologies, Safety, and Mechanism–Modality Matching. Genes. https://doi.org/10.3390/genes17111321
  31. Doench, J. G., Fusi, N., Sullender, M. E., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I. C. P., Tóthová, Z., Wilen, C. B., Orchard, R. C., Virgin, H. W., Listgarten, J., et al. (2016). Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature Biotechnology. https://doi.org/10.1038/nbt.3437
  32. Sambrook, J., Fritsch, E., & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. UCLA - Biblioteca de Ciencias de la Salud. openalex.org/W2144634347
  33. Garneau, J. E., Dupuis, M., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010). The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature. https://doi.org/10.1038/nature09523
  34. Fieder, J., Schneider, S., & Fischer, S. (2026). The historical evolution of CHO cell line development for biologics production: 60 years and still counting. Critical Reviews in Biotechnology. https://doi.org/10.1080/07388551.2026.2738418
  35. Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., OOST, J. v. d., & Koonin, E. V. (2011). Evolution and classification of the CRISPR–Cas systems. Nature Reviews Microbiology. https://doi.org/10.1038/nrmicro2577
  36. Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., Horvath, P., Moineau, S., et al. (2015). An updated evolutionary classification of CRISPR–Cas systems. Nature Reviews Microbiology. https://doi.org/10.1038/nrmicro3569
  37. Darty, K., Denise, A., & Ponty, Y. (2009). VARNA: Interactive drawing and editing of the RNA secondary structure. Bioinformatics. https://doi.org/10.1093/bioinformatics/btp250
  38. Cong, L., Ran, F. A., Cox, D. B., Lin, S., Barretto, R. P. J., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., & Zhang, F. (2013). Multiplex Genome Engineering Using CRISPR/Cas Systems. Science. https://doi.org/10.1126/science.1231143
  39. Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013). Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression. Cell. https://doi.org/10.1016/j.cell.2013.02.022
  40. Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern‐Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., Lim, W. A., Weissman, J. S., et al. (2013). CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes. Cell. https://doi.org/10.1016/j.cell.2013.06.044
  41. Garbin, M. (2026). ORFan genes and capsid architectures in giant viruses: two structure-guided hypotheses for biomedical innovation. Medical Hypotheses. https://doi.org/10.1016/j.mehy.2026.112218
  42. Jínek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science. https://doi.org/10.1126/science.1225829
  43. Jínek, M., East, A., Cheng, A. T., Lin, S., Ma, E., & Doudna, J. A. (2013). RNA-programmed genome editing in human cells. eLife. https://doi.org/10.7554/elife.00471
  44. Shuvo, M. N., Ahmed, S., Sarkar., S. S. a. B., Alif, M. I., Hefferon, K. L., & Shohael, A. M. (2026). Integrating Frontier Technologies to Achieve Semi-Dwarfism in Rice: Highlights on Genome Editing and Artificial Intelligence. Crop Breeding Genetics and Genomics. https://doi.org/10.20900/cbgg20260024
  45. Christian, M. L., Čermák, T., Doyle, E., Schmidt, C. L., Zhang, F., Hummel, A. W., Bogdanove, A. J., & Voytas, D. F. (2010). Targeting DNA Double-Strand Breaks with TAL Effector Nucleases. Genetics. https://doi.org/10.1534/genetics.110.120717
  46. Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B., Shmakov, S., Makarova, K. S., Semenova, E., Станиславович, М. Л., Severinov, K., Regev, A., et al. (2016). C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. https://doi.org/10.1126/science.aaf5573
  47. Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., & Zhang, F. (2013). Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells. Science. https://doi.org/10.1126/science.1247005
  48. Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and Applications of CRISPR-Cas9 for Genome Engineering. Cell. https://doi.org/10.1016/j.cell.2014.05.010
  49. Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., Cradick, T. J., Marraffini, L. A., et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nature Biotechnology. https://doi.org/10.1038/nbt.2647
  50. Huang, P., Wu, W., Min, Y., Zhang, Y., Tao, Y., Liu, Z., Wei, Z., & Peng, X. (2026). Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation. Experimental Hematology and Oncology. https://doi.org/10.1186/s40164-026-00848-3
  51. Mali, P., Yang, L., Esvelt, K. M., Aach, J., Güell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013). RNA-Guided Human Genome Engineering via Cas9. Science. https://doi.org/10.1126/science.1232033
  52. Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020). Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nature Nanotechnology. https://doi.org/10.1038/s41565-020-0669-6
  53. Platt, R. J., Chen, S., Zhou, Y., Yim, M., Swiech, L. J., Kempton, H., Dahlman, J. E., Parnas, O., Eisenhaure, T., Jovanović, M., Graham, D. B., Jhunjhunwala, S., et al. (2014). CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling. Cell. https://doi.org/10.1016/j.cell.2014.09.014
  54. Ruiz, R., Martinez-Martinez, A., Delicado-Mateo, R., Baldanta, S., Montagud‐Martínez, R., & Rodrigo, G. (2026). Computational Design of Prokaryotic Translation Regulation Based on RNA-Binding Proteins. Methods in molecular biology. https://doi.org/10.1007/978-1-0716-5583-2_4
  55. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007). CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes. Science. https://doi.org/10.1126/science.1138140
  56. Du, R., Wang, W., Xie, J., Li, Y., Wu, N., & Xu, Q. C. (2026). Clustered Regularly Interspaced Palindromic Repeats–Cas Genome-Editing Systems in Filamentous Fungi: Current Tools, Optimization Strategies, and Future Perspectives. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c12748
  57. Bae, S., Park, J., & Kim, J. (2014). Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. https://doi.org/10.1093/bioinformatics/btu048
  58. Ali, S., Hussian, C. H. A. C., & Goh, H. (2026). Systems biology and synthetic engineering of probiotic yeasts. Biotechnology Advances. https://doi.org/10.1016/j.biotechadv.2026.109084
  59. Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M. R., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., Aryee, M. J., & Joung, J. K. (2014). GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nature Biotechnology. https://doi.org/10.1038/nbt.3117
  60. Zhang, S., Yuzhen, H., Zili, Z., Huang, W., Baosheng, Z., & Chan, Y. (2026). Research progress of gene correction for genetic diseases via in vivo prime editing. Molecular Genetics and Genomics. https://doi.org/10.1007/s00438-026-02535-8
  61. Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Bárcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., Nureki, O., & Zhang, F. (2014). Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. https://doi.org/10.1038/nature14136
  62. Xie, S., He, Z., & Yin, H. (2026). Efficient and precise large-scale genomic duplication using amplification editing. Nature Protocols. https://doi.org/10.1038/s41596-026-01454-7
  63. Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P., Dickman, M. J., Makarova, K. S., Koonin, E. V., & OOST, J. v. d. (2008). Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes. Science. https://doi.org/10.1126/science.1159689
  64. Roberts, T. C., Langer, R., & Wood, M. J. A. (2020). Advances in oligonucleotide drug delivery. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-020-0075-7
  65. Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends in biotechnology. https://doi.org/10.1016/j.tibtech.2013.04.004
  66. Leng, T., Lv, Y., Rao, C., Zhu, X., Jiang, Y., Hu, S., Rao, C., & Ma, X. (2026). miR-138-5p: From Multidimensional Tumor-Suppressive Regulatory Networks to Nanocarrier-Based Delivery for Solid Tumor Therapy. DARU Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-026-00683-1
  67. Tim, W., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2013). Genetic Screens in Human Cells Using the CRISPR-Cas9 System. Science. https://doi.org/10.1126/science.1246981
  68. Jiang, W., Bikard, D., Cox, D. B., Zhang, F., & Marraffini, L. A. (2013). RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nature Biotechnology. https://doi.org/10.1038/nbt.2508
  69. Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J. J., & Joung, J. K. (2013). Efficient genome editing in zebrafish using a CRISPR-Cas system. Nature Biotechnology. https://doi.org/10.1038/nbt.2501
  70. Ma, X., Zhang, Q., Zhu, Q., Liu, W., Chen, Y., Qiu, R., Wang, B., Yang, Z., Li, H., Lin, Y., Xie, Y., Shen, R., et al. (2015). A Robust CRISPR/Cas9 System for Convenient, High-Efficiency Multiplex Genome Editing in Monocot and Dicot Plants. Molecular Plant. https://doi.org/10.1016/j.molp.2015.04.007
  71. Wang, X., Shi, X., Zheng, X., Ding, Y., Jing, Y., Zhang, J., Wang, J., Li, H., & Zhao, C. (2026). A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119360
  72. Lu, X., Liu, Y., Peng, X., Chen, J., Lu, J., & Zhou, T. (2026). In Vivo Continuous Evolution Systems: Overview, Principles and Applications. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00481
  73. Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nature Biotechnology. https://doi.org/10.1038/nbt.2623
  74. Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014). Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nature Biotechnology. https://doi.org/10.1038/nbt.2808
  75. Pien, Y., Li, H. z., Bulliard, G., Liu, H., Durbacz, M. Z., Xu, Z., Chai, A. C., Chemello, F., Sanchez‐Ortiz, E., Zabaleta, N., Vandenberghe, L. H., Liu, N., et al. (2026). A single liver-sparing myotropic AAV ameliorates muscular dystrophy in humanized mice by base editing. Journal of Clinical Investigation. https://doi.org/10.1172/jci202378
  76. Lin, Z., Akin, H., Rao, R., Hie, B., Zhu, Z., Lu, W., Smetanin, N., Verkuil, R., Kabeli, O., Shmueli, Y., Costa, A. d. S., Fazel-Zarandi, M., et al. (2023). Evolutionary-scale prediction of atomic-level protein structure with a language model. Science. https://doi.org/10.1126/science.ade2574
Feedback